Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up - Should You Buy?

Key Points

• Shares gapped up pre-market from $75.03 to an $80.5750 open (last $80.45), trading up about 9.6% on light volume (250 shares) and sitting above its 50- and 200-day moving averages ($76.55 and $74.62).
• Analysts are mixed: BNP Paribas Exane upgraded to Outperform on Jan 5 while Citigroup remains Neutral, and MarketBeat shows an average rating of Hold (1 Buy, 3 Hold).
• Eurofins Scientific is a global provider of bioanalytical testing and laboratory services for pharmaceutical, food, environmental and agriscience sectors, founded in 1987 and headquartered in Luxembourg.

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $75.03, but opened at $80.5750. Eurofins Scient shares last traded at $80.45, with a volume of 250 shares trading hands.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. BNP Paribas Exane raised shares of Eurofins Scient to an "outperform" rating in a report on Monday, January 5th. Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a report on Monday, February 2nd. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold".

Eurofins Scient Trading Up 9.6%

The firm's fifty day moving average is $76.55 and its 200-day moving average is $74.62.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.